用于肿瘤治疗的放射性药物

范我

用于肿瘤治疗的放射性药物

范我

文章导航 > 国际放射医学核医学杂志 > 2004, 28 > 1: (21-25)

引用本文:

Citation:

用于肿瘤治疗的放射性药物

范我

215007 苏州, 苏州大学放射医学与公共卫生学院
基金项目:
江苏省省级重点实验室开放课题基金(KJSO1010)
中图分类号: R817.5

Radiopharmaceuticals for tumor therapy

FAN Wo

School of Radiation Medicine and Public Health, Suzhou University, Suzhou 215007, China
CLC number: R817.5

摘要: 由于恶性肿瘤靠单一治疗手段往往难以达到根治效果,目前,常采用多学科的综合治疗方法,其中,放射性核素内照射治疗的手段正逐渐受到重视。本文阐述了对放射性治疗药物的要求,对常用的肿瘤治疗放射性药物,包括一般化合物药物、放射性标记的胶体和颗粒,以及放射性导向治疗药物的种类和应用作了简要介绍。
- 恶性肿瘤 /
- 放射性药物 /
- 治疗
Abstract: Recently, multimodality treatment for cancer is used to improve the therapeutic re-sponse and prolongate survival of the patients.Radionuclides therapy is a promising technology as a comple-mental method of surgery, chemotherapy and external radiotherapy.The requirements for ra-dionuclide therapy are explicated in this paper.Radiopharmaceuticals including chemical drugs, radio-labeled col-loids and particles, as well as immunotherapeutic agents and peptides directed against ma-lignant tumor in clinical application are illustrated.
- malignant tumor /
- radiopharmaceuticals /
- therapy
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Mariani G, Bodei L, Adelstein SJ, et al. Emerging roles for radiometabolic therapy of tumors based on auger electron emission[J]. J Nucl Med, 2000, 41(9):1519-1521.
[2]	Partensky C, Sassolas G, Henry L, et al. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma:a phase 2 clinical study[J]. Arch Surg, 2000, 135(11):1298-1300.
[3]	Larsen SW, Rinvar E, Svendsen O, et al. Determination of the disappearance rate of iodine-125 labelled oils from the injection site after intramuscular and subcutaneous administration to pigs[J]. Int J Pharm, 2001, 230(1):67-75.
[4]	Blasco JC. Brachytherapy[J]. Urology, 2000, 55(2):306-308.
[5]	Boland A, Ricard M, Opolon P, et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy[J]. Cancer Res, 2000,60(13):3484-3492.
[6]	Krishnamurthy GT, Swailem FM, Swailem SC, et al. Tin117(4+)DTPA:Pharmacokinetics and imaging characteristics in patients with metastatic bone pain[J]. J Nucl Med,1997, 38(2):230-235.
[7]	Goddu SM, Bishayee A, Bouchet LG, et al. Marrow toxicity of ³³P-versus ³²P-orthophosphate:implications for therapy of bone pain and bone metastases[J]. J Nucl Med, 2000, 41(5):941-951.
[8]	Makhija S, Howden N, Edwards R, et al. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma:a retrospective review[J]. Gynecol oncol, 2002, 85(1):53-58.
[9]	Yu JF, Yin DZ, Min XF, et al.(¹⁸⁸Re)Rhenuim sulfide suspensio n:a potential radiopharmaceutical for treatment folowing intratumor injection[J]. Nucl Med Biol, 1999, 26:(5) 573-579.
[10]	Nijsen F, Rook D, Brandt C, et al. Targeting of liver tumor in rats by selective delivery of holmium-166 loaded microsphers:a biodistribution study[J]. J Eur Nucl Med, 2001,28(6):743-749.
[11]	Jacobs A, Tjuvajev JG, Dubrovin M, et al. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo[J]. Cancer Res,2001, 61(7):2983-2995.
[12]	de Jong M, Breeman WAP, Bernard WA, et al.[¹⁷⁷LuDOTA⁰, Tyr³] octreotate for somatostatin receptor-targeted radionuclide therapy[J]. Int J Cancer, 2001, 92(5):628-633.
[13]	Eisenwiener KP, Prata MI, Buschmann I, et al. NODAGATOC, a new chelator-coupled somatostatin analogue labeled with[⁶⁷Ga/⁶⁸Ga] and ¹¹¹In for SPECT, PET, and targeted therapeutic applications of somatostatin receptor(hsst2)expressing tumors[J]. Bioconjug Chem, 2002,13(3):530-541.
[14]	Janson ET, Westlin JE, Ohrvall U, et al. Nuclear localization of ¹¹¹In after intravenous injection of [¹¹¹In-DTPA-DPhe¹]-octreotide in patients with neuroendocrine tumors[J].J Nucl Med, 2000, 41(9):1514-1518.

[1]	刘英 , 陈龙华 , 巩湘浩 , 吕国士 . VEGF与肿瘤的放射治疗. 国际放射医学核医学杂志, 2003, 27(4): 183-186.
[2]	刘康其 , 周海中 . 放射性药物联合双膦酸盐类药物治疗肿瘤骨转移研究现状. 国际放射医学核医学杂志, 2019, 43(2): 166-170. doi: 10.3760/cma.j.issn.1673-4114.2019.02.012
[3]	顾涛颖 , 石洪成 . 放射性药物治疗肿瘤骨转移性骨痛的作用. 国际放射医学核医学杂志, 2010, 34(2): 88-90. doi: 10.3760/cma.j.issn.1673-4114.2010.02.006
[4]	吴凡 , 李林法 , 易贺庆 . α粒子放射性药物在骨转移瘤治疗中的应用进展. 国际放射医学核医学杂志, 2022, 46(2): 112-115. doi: 10.3760/cma.j.cn121381-202106027-00134
[5]	刘丽波 , 张海英 . 放射性膀胱炎的治疗和预防. 国际放射医学核医学杂志, 2000, 24(3): 135-137.
[6]	陆蒋惠文 , 张舒羽 , 张杰 , 余道江 . 放射性皮肤损伤的治疗进展. 国际放射医学核医学杂志, 2021, 45(7): 461-469. doi: 10.3760/cma.j.cn121381-202005043-00030
[7]	张紫薇 , 程刚 . 放射性核素在嗜铬细胞瘤诊断与治疗中的应用进展. 国际放射医学核医学杂志, 2019, 43(1): 82-87. doi: 10.3760/cma.j.issn.1673-4114.2019.01.014
[8]	闵锐 , 潘真 , 李雨 . 急性放射病的分度和治疗——介绍美国国家战略储备辐射工作组关于急性放射病治疗的建议之二. 国际放射医学核医学杂志, 2005, 29(6): 272-278.
[9]	王欣茹 , 罗庆良 , 王宝勤 , 董书魁 . 中子急性放射病的特点及治疗研究进展. 国际放射医学核医学杂志, 2003, 27(4): 178-181.
[10]	弓全胜 , 夏振民 . 放射性药物的给药后归宿. 国际放射医学核医学杂志, 1998, 22(4): 167-172,176.
[11]	杨建权 , 李晔 , 张现忠 . 基于小分子肽的放射性药物. 国际放射医学核医学杂志, 2003, 27(4): 157-161.

点击查看大图

计量

文章访问数: 1144
HTML全文浏览量: 103
PDF下载量: 2

用于肿瘤治疗的放射性药物

范我

215007 苏州, 苏州大学放射医学与公共卫生学院

收稿日期: 2003-04-03

基金项目: 江苏省省级重点实验室开放课题基金(KJSO1010)

关键词:

摘要: 由于恶性肿瘤靠单一治疗手段往往难以达到根治效果,目前,常采用多学科的综合治疗方法,其中,放射性核素内照射治疗的手段正逐渐受到重视。本文阐述了对放射性治疗药物的要求,对常用的肿瘤治疗放射性药物,包括一般化合物药物、放射性标记的胶体和颗粒,以及放射性导向治疗药物的种类和应用作了简要介绍。